Core Viewpoint - Recently, two major products from Buchang Pharma, Xuanfei Baidu Granules and Tongbianling Capsules, successfully passed the Indonesian Ministry of Health's review and obtained drug registration certificates [1] Group 1: Product Registration - Xuanfei Baidu Granules has previously been registered in Canada, Uzbekistan, and Kazakhstan [1] - Along with the new products, eight renewal registration products, including Buchang Stabilizing Granules, Kelu Oral Liquid, and Yangzheng Heji, were also successfully approved [1] Group 2: Market Expansion - Currently, Buchang Pharma has over 20 products listed for sale in Indonesia [1] - The addition of these new products not only enriches Buchang Pharma's product matrix in Indonesia but also represents a solid step in the "internationalization of traditional Chinese medicine" strategy [1] - This move highlights the unique value and broad recognition of traditional Chinese medicine on the international stage [1]